• CircRHOBTB3 Restricts Prostate Cancer Progression via NONO/M

  2026-04-20

  This study identifies circRHOBTB3 as a tumor suppressor in prostate cancer, revealing its mechanism of action through the cytoplasmic sequestration of NONO and subsequent suppression of MAOA expression. The findings highlight circRHOBTB3's potential as a clinical biomarker and provide mechanistic insights relevant to cancer metastasis research.

• Bifendate (DDB): Applied Protocols for Hepatoprotection Rese

  2026-04-20

  Bifendate (DDB) is a robust hepatoprotection agent and autophagy inhibitor, uniquely suited for translational liver disease research. This article details optimized experimental workflows, troubleshooting guidance, and cross-study insights that empower researchers to maximize data quality and reproducibility with Bifendate (DDB).

• Redefining Bioluminescent Reporter mRNA for Translational Im

  2026-04-19

  This thought-leadership article explores the mechanistic innovations and translational strategies behind Firefly Luciferase mRNA (ARCA, 5-moUTP), highlighting its role as a next-generation bioluminescent reporter. Integrating peer-reviewed advances in mRNA engineering, nanoparticle delivery, and immune evasion, we offer actionable insights for researchers in gene expression, cell viability, and in vivo imaging workflows. The article contextualizes APExBIO's product within the competitive landscape and points toward the future of RNA-based translational research.

• GSK343: Precision EZH2 Inhibitor Transforming Epigenetic Can

  2026-04-18

  GSK343 enables highly selective inhibition of EZH2, unlocking advanced workflows for mechanistic studies of histone H3K27 trimethylation and epigenetic regulation in cancer. Its robust selectivity, cell permeability, and reproducible performance make it the gold-standard tool for dissecting the PRC2 pathway and accelerating translational oncology discoveries.

• Dextrose (D-glucose) in Tumor Immunometabolism: Mechanistic

  2026-04-17

  This thought-leadership article explores the pivotal role of Dextrose (D-glucose) in unraveling the metabolic and immunological interplay within the hypoxic tumor microenvironment. Drawing on recent advances in cancer biology, the discussion bridges mechanistic understanding with actionable recommendations for translational researchers. The narrative demonstrates how APExBIO's high-purity Dextrose (D-glucose) (SKU: A8406) enables reproducible, cutting-edge investigations, and offers practical protocol guidance for advanced metabolic and immunometabolic assays.

• ABT-263 (Navitoclax): Applied Workflows for Apoptosis Assays

  2026-04-16

  ABT-263 (Navitoclax) is redefining cancer biology research as a high-affinity Bcl-2 family inhibitor, enabling precise, reproducible dissection of mitochondrial and caspase-dependent apoptosis. This article details practical experimental workflows, troubleshooting, and novel use-cases informed by cutting-edge primary leukemia research and APExBIO’s robust product formulation.

• Nile Red: Precision Lipid Droplet Staining for Metabolic Res

  2026-04-15

  Nile Red (Nile blue oxazone) delivers dual-emission, high-sensitivity lipid droplet staining—unlocking detailed insights into lipid storage dynamics and metabolism. With robust protocols and troubleshooting guidance, APExBIO’s Nile Red empowers researchers to address complex biological questions from cancer biomarker discovery to advanced lipidomics.

• MALAT1 Regulates TDP-43 Binding and Cell Viability in Neuron

  2026-04-14

  This study reveals that the long noncoding RNA MALAT1 modulates TDP-43 binding to mRNA and influences cell survival in human cell lines. These findings clarify critical RNA–protein interactions relevant to neurodegeneration and provide a technical foundation for mechanistic studies of RNA regulation in neuronal health and disease.

• Vidarabine Monohydrate: Elevating Antiviral Strategies in Tr

  2026-04-13

  This thought-leadership article explores the mechanistic, translational, and workflow dimensions of Vidarabine monohydrate (also known as Spongoadenosine monohydrate), emphasizing its role as a high-purity antiviral nucleoside analog for DNA virus research. It offers actionable guidance for researchers, compares product performance, and contextualizes recent breakthroughs in the field. The piece also builds upon prior literature to provide a nuanced perspective beyond standard product descriptions.

• Captopril in Translational Science: ACE Inhibition and Beyon

  2026-04-12

  Explore the mechanistic depth and translational potential of Captopril, a gold-standard ACE inhibitor. This article integrates rigorous evidence for hypertension and oncology applications, bridges cardiovascular and gastrointestinal research via bradykinin signaling, and delivers actionable strategies for experimental scientists. Discover how APExBIO’s Captopril (SKU A4078) supports reproducible, high-impact research across domains.

• 2-NBDG: Optimizing Glucose Uptake Assays for Metabolic Resea

  2026-04-12

  2-NBDG (2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose) enables sensitive, fluorescence-based quantification of cellular glucose uptake across diverse models. This guide translates the latest mechanistic research and best practices into actionable workflows, troubleshooting insights, and assay enhancements for reliable metabolic phenotyping.

• Metronidazole in Research: OAT3 Inhibition & Microbiota Tool

  2026-04-11

  Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) enables targeted modulation of organic anion transporters, offering advanced control in drug-drug interaction and gut microbiota studies. This guide translates bench evidence into actionable protocols, comparative workflows, and troubleshooting strategies for high-impact research.

• Applied Cancer Research with Anti-ROR1 Antibody (Zilovertama

  2026-04-11

  Anti-ROR1 Antibody (Zilovertamab) unlocks highly specific Wnt5a-induced ROR1 signaling inhibition, driving reproducible anti-tumor workflows from ELISA to in vivo models. This guide delivers stepwise protocols, experimental optimizations, and troubleshooting insights tailored for advanced cancer research teams.

• Redefining Cardiovascular and Hematopoietic Research: The...

  2026-04-10

  Metoprolol Tartrate, a cardioselective β1-adrenergic receptor blocker, is transforming cardiovascular and regenerative medicine research. This article delivers mechanistic insight and translational guidance for researchers navigating hypertension, arrhythmia, and heart failure models—while integrating new evidence on hematopoietic regeneration. By contrasting selective versus nonselective β-blockade, we chart a visionary path for precision research, highlighting the unique strengths of APExBIO’s Metoprolol Tartrate.

• Metoprolol Tartrate: Selective β1 Blocker for Cardiovascu...

  2026-04-09

  Explore the advanced scientific applications of Metoprolol Tartrate as a selective β1-adrenergic receptor blocker in cardiovascular and hematopoietic research. This article offers a unique, in-depth analysis of its mechanistic selectivity, translational impact, and experimental advantages, providing insights beyond standard cardiovascular pharmacology.

407 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page